Literature DB >> 4402554

[Actions of alpha-sympathomimetics on nervous structures].

H Schmitt.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4402554

Source DB:  PubMed          Journal:  Actual Pharmacol (Paris)        ISSN: 0567-8854


× No keyword cloud information.
  10 in total

1.  Background of the drug treatment of glaucoma.

Authors:  P A Van Zwieten
Journal:  Doc Ophthalmol       Date:  1977-09-30       Impact factor: 2.379

Review 2.  Drugs interacting with alpha adrenoceptors.

Authors:  P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 3.  Pharmacology of centrally acting hypotensive drugs.

Authors:  P A van Zwieten
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

4.  The influence of acute and chronic cervical sympathectomy on the ocular hypotensive effect of clonidine.

Authors:  H C Innemee; J D van Ommeren; P A van Zwieten
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-11

5.  The influence of clonidine on intraocular pressure.

Authors:  H C Innemee; P A van Zwieten
Journal:  Doc Ophthalmol       Date:  1979-03-15       Impact factor: 2.379

6.  Lipophilicity and brain disposition of clonidine and structurally related imidazolidines.

Authors:  P B Timmermans; A Brands; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

7.  The central ocular hypotensive effect of clonidine.

Authors:  H C Innemee; P A van Zwieten
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-04-02

8.  Effect of clonidine on sleep patterns in man.

Authors:  A Autret; M Minz; T Beillevaire; H P Cathala; H Schmitt
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

9.  Clonidine effect on insulin secretion and lipolysis in man.

Authors:  V Saibene; G Martinelli; F Vasconi; G Pozza
Journal:  Acta Diabetol Lat       Date:  1978 May-Aug

Review 10.  Different types of centrally acting antihypertensives and their targets in the central nervous system.

Authors:  P A van Zwieten; J P Chalmers
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.